XIAPによるカスパース7抑制の構造的基礎
J Chai1, E Shiozaki, S M Srinivasula
1Department of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Washington Road, Princeton, NJ 08544, USA.
Cell
|March 21, 2001
まとめ
アポトーシス阻害剤 (IAP) タンパク質は,カスパスを阻害することによって細胞死を阻害する. この研究は,XIAPペプチド結合カスペーゼ-7の結晶構造を明らかにし,新しいカスペーゼ阻害剤を設計するための洞察を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 分子生物学は分子生物学である.
背景:
- アポトーシス阻害剤 (IAP) タンパク質は,カスペスを標的としてアポトーシスを調節する.
- カスパースの活動は,プログラムされた細胞死において極めて重要です.
- カスパース阻害剤の相互作用を理解することは,治療の開発の鍵です.
研究 の 目的:
- XIAPによるカスパース7抑制の構造的基礎を解明する.
- カスパース阻害におけるBIRドメインの役割を調査する.
- 新種のカスパース阻害剤の設計のための基礎を提供すること.
主な方法:
- カスパース-7とXIAPペプチド複合体の構造を決定するX線結晶学.
- 抑制活性を評価するための生化学的測定法.
- タンパク質とタンパク質の相互作用の構造分析.
主要な成果:
- 18残基のXIAPペプチドと複合したカスパース-7の結晶構造は2.45A解像度で決定された.
- XIAPペプチドは,カスパース-7の触媒槽に結合し,既知の阻害剤の相互作用を模倣する.
- 生化学的および構造的データは,BIRドメインがカスパーゼ3および-7を阻害するために不可欠ではないことを示しています.
結論:
- カスパース-7とのXIAPペプチド相互作用は,カスパース抑制のための新しい構造モデルを提供します.
- BIRドメインは,カスパーゼ3および-7に対するXIAPの抑制機能のために必要不可欠です.
- この構造的洞察は,次世代のアポトーシス調節薬の合理的な設計を容易にする.
関連する概念動画
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...


